- Report
- February 2023
- 81 Pages
Global
From €3113EUR$3,495USD£2,709GBP
- Report
- December 2022
- 519 Pages
Global
From €2227EUR$2,500USD£1,938GBP
- Drug Pipelines
- December 2022
- 107 Pages
Global
From €13357EUR$14,995USD£11,623GBP
- Report
- November 2022
- 565 Pages
Global
From €2227EUR$2,500USD£1,938GBP
- Report
- October 2022
- 411 Pages
Global
From €2227EUR$2,500USD£1,938GBP
- Drug Pipelines
- June 2022
- 101 Pages
Global
From €13357EUR$14,995USD£11,623GBP
- Clinical Trials
- December 2021
- 99 Pages
Global
From €2227EUR$2,500USD£1,938GBP
- Report
- December 2019
- 190 Pages
Global
From €13357EUR$14,995USD£11,623GBP
- Report
- December 2019
- 63 Pages
Global
From €3558EUR$3,995USD£3,097GBP
- Report
- April 2024
- 80 Pages
China
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP
- Report
- April 2024
- 80 Pages
France
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP
- Report
- April 2024
- 80 Pages
Germany
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP
- Report
- April 2024
- 80 Pages
India
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP
- Report
- April 2024
- 80 Pages
Poland
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP
- Report
- April 2024
- 80 Pages
Russia
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP
- Report
- April 2024
- 80 Pages
South Korea
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP
- Report
- April 2024
- 80 Pages
United States
From €668EUR$750USD£581GBP
€1336EUR$1,500USD£1,163GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more